Shon Green

Company: Adicet Bio

Job title: Vice President, Nonclinical Development

Seminars:

ADI-270, An Allogeneic Armored γδ CAR T-Cell Product with Potential to Address the Challenges of Targeting Solid Tumors 9:30 am

Share ADI-270 design and product characteristics Preclinical data supporting potential to overcome challenges in solid tumor targeting Discuss how ADI-270 is differentiated compared to conventional αβ CAR-T benchmarksRead more

day: Post-Conference Solid Tumor Focus Day